Episteme Prognostics, Inc.
BiotechnologyPrecision medicine
Brooklyn, NY
2021
founded
About
Episteme Prognostics, Inc. is a pioneering precision medicine company dedicated to revolutionizing pancreatic cancer diagnosis and treatment. By focusing on the development of groundbreaking diagnostic tests, the company aims to enhance therapeutic decisions, ultimately improving patient outcomes. Their innovative technology leverages epigenetic biomarkers to provide critical insights into treatment responses for patients diagnosed with this challenging disease.
Company Values
Episteme Prognostics stands out by utilizing epigenetic biomarkers to create diagnostic tools that predict therapeutic responses in pancreatic cancer, an area with historically limited options.